David Bartkovitz
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
-
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
Papers in
-
- Microtubule and mitosis dynamics 4
-
- Regulation of Appetite and Obesity 3
- Co-authors
- Xin‐Jie Chu (7 shared papers)Zoran Filipovic (3 shared papers)Zhuming Zhang (3 shared papers)Kelli Glenn (3 shared papers)Christian Tovar (3 shared papers)Bradford J. Graves (3 shared papers)Nan Jiang (3 shared papers)Lyubomir T. Vassilev (3 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Medicinal Chemistry (2 papers)The Journal of Organic Chemistry (1 paper)Bioorganic & Medicinal Chemistry (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
David Bartkovitz
9 papers receiving 757 citations
David Bartkovitz's Hit Papers
Peers
Comparison fields: 5 of 65
- Oncology 421
- Molecular Biology 493
- Biotechnology 52
- Cell Biology 98
- Organic Chemistry 160
Countries citing papers authored by David Bartkovitz
This map shows the geographic impact of David Bartkovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bartkovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bartkovitz more than expected).
Fields of papers citing papers by David Bartkovitz
This network shows the impact of papers produced by David Bartkovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bartkovitz. The network helps show where David Bartkovitz may publish in the future.
Co-authors
The 25 scholars most cited alongside David Bartkovitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development Hit paper breakdown → | 2013 | 496 |
| 2 | 2006 | 101 | |
| 3 | 2013 | 79 | |
| 4 | 2014 | 50 | |
| 5 | 2011 | 28 | |
| 6 | 2005 | 11 | |
| 7 | 1992 | 8 | |
| 8 | 2005 | 7 | |
| 9 | 2001 | 4 |
About David Bartkovitz
David Bartkovitz is a scholar working on Cell Biology, Endocrine and Autonomic Systems, Oncology, Nutrition and Dietetics and Molecular Biology, having authored 9 papers that have together received 784 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Microtubule and mitosis dynamics (4 papers), Biochemical Analysis and Sensing Techniques (3 papers), Regulation of Appetite and Obesity (3 papers), Ubiquitin and proteasome pathways (3 papers), Cancer Mechanisms and Therapy (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper) and Crystal structures of chemical compounds (1 paper). The work is most often cited by research in Oncology (421 citations), Molecular Biology (493 citations), Biotechnology (52 citations), Cell Biology (98 citations) and Organic Chemistry (160 citations). David Bartkovitz has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Xin‐Jie Chu, Zoran Filipovic, Zhuming Zhang, Kelli Glenn, Christian Tovar, Bradford J. Graves, Nan Jiang, Lyubomir T. Vassilev, Kathryn E. Packman and Qingjie Ding. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, The Journal of Organic Chemistry, Bioorganic & Medicinal Chemistry and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.